Evidence map›Paper›PMID 34439769›Full record

ReviewBiomolecules2021

Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review.

Yiyi Chen, Xing Wang, Ling Guan, Yilong Wang

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Do white matter hyperintensities account for the relationship between discrimination and memory?Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Article
  7. Regional White Matter Lesion Load in Elderly Patients With Somatic vs. Non-Somatic Delusional Disorder.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. The role of lipid metabolism in cognitive impairment.Arquivos de neuro-psiquiatria · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Alcohol Use Disorder and Dementia: A Review.Alcohol research : current reviews · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yiyi ChenDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.ORCID 0000-0002-5363-8898
Xing WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.ORCID 0000-0002-2435-6533
Ling GuanDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Yilong WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Capital Medical University · CNChongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

White matter hyperintensities (WMHs) of presumed vascular origin are one of the imaging markers of cerebral small-vessel disease, which is prevalent in older individuals and closely associated with the occurrence and development of cognitive impairment. The heterogeneous nature of the imaging manifestations of WMHs creates difficulties for early detection and diagnosis of vascular cognitive impairment (VCI) associated with WMHs. Because the underlying pathological processes and biomarkers of WMHs and their development in cognitive impairment remain uncertain, progress in prevention and treatment is lagging. For this reason, this paper reviews the status of research on the features of WMHs related to VCI, as well as mediators associated with both WMHs and VCI, and summarizes potential treatment strategies for the prevention and intervention in WMHs associated with VCI.

Indexed as

Amyloid beta-PeptidesAnimalsBiomarkersBlood-Brain BarrierBrainBrain MappingCognitive DysfunctionDementia, VascularHumansInflammationMagnetic Resonance ImagingMiceRisk Factorstau ProteinsWhite MatterAmyloid beta-PeptidesBiomarkersMAPT protein, humantau Proteinscerebral small vessel diseasecognitive impairmentwhite matter hyperintensities

Identifiers

PMID34439769
PMCPMC8391787
OpenAlexW3184676096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.